These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8762465)

  • 1. [Population pharmacokinetics/pharmacodynamics of magnesium sulfate in pregnancy induced hypertensive gravidas treated with the drug].
    Rui JZ; Yang YC; Wang YN; Chen G
    Yao Xue Xue Bao; 1996; 31(2):81-5. PubMed ID: 8762465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic-pharmacodynamic model of magnesium sulfate in treatment of pregnancy-induced hypertension].
    Chen G; Lu JF; Cao W
    Zhongguo Yao Li Xue Bao; 1991 May; 12(3):222-5. PubMed ID: 1781283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women.
    Lu J; Pfister M; Ferrari P; Chen G; Sheiner L
    Clin Pharmacokinet; 2002; 41(13):1105-13. PubMed ID: 12403646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of magnesium in preeclampsia.
    Chuan FS; Charles BG; Boyle RK; Rasiah RL
    Am J Obstet Gynecol; 2001 Sep; 185(3):593-9. PubMed ID: 11568783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of manual versus ambulatory blood pressure measurements with pharmacokinetic-pharmacodynamic modeling of antihypertensive compounds: application to moxonidine.
    Trocóniz IF; de Alwis DP; Tillmann C; Callies S; Mitchell M; Schaefer HG
    Clin Pharmacol Ther; 2000 Jul; 68(1):18-27. PubMed ID: 10945312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium sulfate effectively reduces blood pressure in an animal model of preeclampsia.
    Standley CA; Batia L; Yueh G
    J Matern Fetal Neonatal Med; 2006 Mar; 19(3):171-6. PubMed ID: 16690511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study.
    Salinger DH; Mundle S; Regi A; Bracken H; Winikoff B; Vicini P; Easterling T
    BJOG; 2013 Jun; 120(7):894-900. PubMed ID: 23530757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
    Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
    Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of magnesium sulfate in intensive care of severe toxemias of pregnancy (author's transl)].
    Schwarz R; Retzke U; Lauckner W
    Geburtshilfe Frauenheilkd; 1979 Jul; 39(7):604-8. PubMed ID: 467956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of magnesium sulfate on lipid peroxidation and blood pressure regulators in preeclampsia.
    Ariza AC; Bobadilla N; Fernández C; Muñoz-Fuentes RM; Larrea F; Halhali A
    Clin Biochem; 2005 Feb; 38(2):128-33. PubMed ID: 15642274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of magnesium sulfate on large cerebral artery blood flow in preeclampsia.
    Hatab MR; Zeeman GG; Twickler DM
    J Matern Fetal Neonatal Med; 2005 Mar; 17(3):187-92. PubMed ID: 16147821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling.
    van den Bongard HJ; Mathôt RA; van Tellingen O; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):16-24. PubMed ID: 12111107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy.
    Aali BS; Khazaeli P; Ghasemi F
    J Obstet Gynaecol Res; 2007 Apr; 33(2):138-43. PubMed ID: 17441885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements.
    Hempel G; Karlsson MO; de Alwis DP; Toublanc N; McNay J; Schaefer HG
    Clin Pharmacol Ther; 1998 Dec; 64(6):622-35. PubMed ID: 9871427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum magnesium and calcium ions in patients with severe pre-eclampsia/eclampsia undergoing magnesium sulfate therapy.
    Aali S; Khazaeli P; Ghasemi F; Mehdizadeh A
    Med Sci Monit; 2007 Apr; 13(4):CR191-4. PubMed ID: 17392650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of ketanserin in pre-eclamptic patients and its association with antihypertensive response.
    Hanff LM; Visser W; Steegers EA; Vulto AG
    Fundam Clin Pharmacol; 2005 Oct; 19(5):585-90. PubMed ID: 16176338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.
    Jolling K; Perez Ruixo JJ; Hemeryck A; Vermeulen A; Greway T
    Eur J Pharm Sci; 2005 Apr; 24(5):465-75. PubMed ID: 15784336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.
    Anthony J; Johanson RB; Duley L
    Drug Saf; 1996 Sep; 15(3):188-99. PubMed ID: 8879973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics of Magnesium Sulfate in Preeclampsia and Associated Factors.
    da Costa TX; Azeredo FJ; Ururahy MAG; da Silva Filho MA; Martins RR; Oliveira AG
    Drugs R D; 2020 Sep; 20(3):257-266. PubMed ID: 32642964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.